BEUDAMED
    FDA Adverse Event Malfunction Summary report: N

    COAGUCHEK ® XS SYSTEM

    MDR report key: 2192679 · Received August 5, 2011

    Report

    Report Number
    1823260-2011-04212
    Event Type
    Malfunction
    Date Received
    August 5, 2011
    Date of Event
    June 21, 2011
    Report Date
    February 13, 2012
    Manufacturer
    ROCHE DIAGNOSTICS
    Product Code
    GJS
    PMA / PMN Number
    K062925
    Removal / Correction Number
    NA
    Product Problem
    Yes
    Report Source
    Manufacturer report
    Reporter Location
    KY, US
    Reporter Occupation
    OTHER

    Narratives

    Additional Manufacturer Narrative · 1

    IT WAS UNKNOWN IF THE INITIAL REPORTER SENT REPORT TO THE FDA. PATIENT 2 - (B)(6) MALE PATIENT 2 - WARFARIN, AMIODARONE THIS MEDWATCH REPORT IS FOR THE SUSPECT DEVICE USED IN THE COAGUCHEK XS SYSTEM (LOT NUMBER 20203611, EXPIRATION DATE 05/31/2012). REFERENCE MEDWATCH REPORT WITH A1 PATIENT IDENTIFIER (B)(6) FOR THE SUSPECT DEVICE USED IN THE COAGUCHEK S SYSTEM.

    Description of Event or Problem · 1

    CALLER REPORTS THAT DURING A CORRELATION STUDY THE FOLLOWING COAGUCHEK XS/S RESULTS WERE OBTAINED: 1.9 INR/2.4 INR, 3.2 INR/4.3 INR, 4.6 INR/6.5 INR PATIENT 2'S WEEKLY WARFARIN DOSE WAS DECREASED BASED ON METER READING. NO ADVERSE EVENT REPORTED. REQUESTED RETURN OF SUSPECT SYSTEM AND REPLACEMENT WAS SENT.

    Devices

    Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
    1 COAGUCHEK ® XS SYSTEM PROTHROMBIN TIME TEST STRIPS GJS ROCHE DIAGNOSTICS NA 20203611

    Patients

    Seq Age Sex Outcome Treatment
    1 045 YR WARFARIN